Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+ CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+ CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+ CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by "weak" TCR stimuli. In contrast, the suppressive function of CD4+ CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+ CD25high T cells from either FOXP3+ or FOXP3- IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-gamma production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+ CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of function mutations of Foxp3 lead to the manifestation of the scurfy phenotype in mice, corresponding to the IPEX-syndrome in humans [434].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [434]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Cited by
Items 201–300 of 509
The Role of FOXP3 in Regulating Immune Responses
Vent‐Schmidt, J., Han, J. M., MacDonald, K. G., & Levings, M. K. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.811657 · Cited by 51
Wang, J., Müller, S., Lin, R., Siffert, M., Vuitton, D. A., Wen, H., & Gottstein, B. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.181 · Cited by 44
“These individuals develop aggressive autoimmunity including insulin-dependent diabetes, thyroiditis and eczema [27, 28].”
BackgroundAdair, P., Kim, Y. C., Zhang, A.-H., Yoon, J., & Scott, D. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01117 · Cited by 45
Domev, H., Milkov, I., Itskovitz-Eldor, J., & Dar, A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0097 · Cited by 43
Ahmad, E., Elgohary, T., & Ibrahim, H. (2011) · PubMed · Cited by 50
Sheikhi, A., Shakerian, M., Giti, H., Baghaeifar, M., Jafarzadeh, A., Ghaed, V., Heibor, M., Baharifar, N., Dadafarin, Z., & Bashirpour, G. (2016) · Drug Research · doi:10.1055/s-0035-1569414 · Cited by 45
“…has shown that non-functional, absent Tregs or genetic mutations in Foxp3 induces hypersensi - tivity to intestinal bacterial antigens [36, 37], and impairs the balance of intestinal mucosal immunity to inflammatory injury followed by lymphocytic infiltration of the intestinal mucosa [38, 39].”
BackgroundOkeke, E. B., Okwor, I., & Uzonna, J. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303064 · Cited by 42
T cells, dendritic cells and epithelial cells in intestinal homeostasis
Westendorf, A. M., Fleissner, D., Hansen, W., & Buer, J. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.009 · Cited by 51
Identification of new FOXP3 mutations and prenatal diagnosis of IPEX syndrome
Harbuz, R., Lespinasse, J., Boulet, S., Francannet, C., Creveaux, I., Khelifa, M. B., Jouk, P., Lunardi, J., & Ray, P. F. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2613 · Cited by 41
“(a) Schematic representation of the FOXP3 gene showing the positioning of all published mutations (Chatila et al., 2000; Bennett et al., 2001a; Bennett et al., 2001b; Wildin et al., 2001; Kobayashi et al., 2001; Wildin et al., 2002; Owen et al., 2003; Tanaka et al., 2004; Bacchetta et al., 2006; Myers et al., 2006; Mo…”
BackgroundRole of regulatory T cells in the promotion of transplant tolerance
Shalev, I., Selzner, N., Shyu, W., Grant, D., & Levy, G. (2012) · Liver Transplantation · doi:10.1002/lt.23458 · Cited by 40
Forkhead box P3: The Peacekeeper of the Immune System
Passerini, L., de Sio, F. R. S., Roncarolo, M. G., & Bacchetta, R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.863303 · Cited by 47
“Dysruption of FOXP3 in humans results in loss of suppressive function by Treg cells [41, 50, 51], which is considered the primary cause of disease.”
BackgroundResultInfluentialSelf-citationNademi, Z., Slatter, M. A., Gambineri, E., Mannurita, S. C., Barge, D., Hodges, S., Bunn, S. K., Thomas, J., Haugk, B., Hambleton, S., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.181 · Cited by 40
Goettel, J. A., Biswas, S., Lexmond, W. S., Yeste, A., Passerini, L., Patel, B., Yang, S., Sun, J., Ouahed, J., Shouval, D. S., et al. (2015) · Blood · doi:10.1182/blood-2014-12-618363 · Cited by 46
Self-citationSellebjerg, F. T., Krakauer, M., Khademi, M., Olsson, T. P., & Sørensen, P. S. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04654.x · Cited by 42
Sasaki, M., Ikeda, H., Sawada, S., Sato, Y., & Nakanuma, Y. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044776 · Cited by 42
The Tregs' world according to GARP
Battaglia, M., & Roncarolo, M. G. (2009) · European Journal of Immunology · doi:10.1002/eji.200940117 · Cited by 44
Mohammadnia‐Afrouzi, M., Hosseini, A. Z., Khalili, A., Abediankenari, S., Amari, A., Aghili, B., & Hossein‐Nataj, H. (2016) · Immunological Investigations · doi:10.3109/08820139.2015.1103749 · Cited by 37
“(Bacchetta et al., 2006).”
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation
Narula, M., Lakshmanan, U., Borna, Š., Schulze, J., Holmes, T. H., Harre, N., Kirkey, M., Ramachandran, A., Tagi, V. M., Barzaghi, F., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.013 · Cited by 43
Self-citationAdoptive regulatory T cell therapy: challenges in clinical transplantation
Safinia, N., Sagoo, P., Lechler, R. I., & Lombardi, G. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833bfadc · Cited by 48
Regulatory T cell therapy as individualized medicine for asthma and allergy
Xystrakis, E., Urry, Z., & Hawrylowicz, C. M. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f14d7c · Cited by 41
Primer: Immunity and Autoimmunity
Pietropaolo, M., Surhigh, J. M., Nelson, P. W., & Eisenbarth, G. S. (2008) · Diabetes · doi:10.2337/db07-1691 · Cited by 47
“With loss or abnormalities of antigen-specific regulatory T-cell function, development of diabetes is enhanced both for NOD mice and humans (i.e., in the IPEX syndrome, mutation of FOXP3 leads to neonatal autoimmune diabetes, at times presenting within days of birth).”
BackgroundInfluentialProtective function of sclerosing cholangitis on IBD
Bedke, T., Stumme, F., Tomczak, M., Steglich, B., Jia, R., Bohmann, S., Wittek, A., Kempski, J., Göke, E., Böttcher, M., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-330856 · Cited by 45
“Interestingly, patients with genetic mutations 42 in the FOXP3 gene, that have no or non-functional Treg cells, develop severe intestinal inflammation.”
Hwang, J. L., Park, S. Y., Ye, H., Sanyoura, M., Pastore, A. N., Carmody, D., del Gaudio, D., Wilson, J. F., Hanis, C. L., Liu, X., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12612 · Cited by 38
“However, a number of studies have reported normal protein expression even in cases with mutations causing the complete IPEX syndrome.(3,12,13) Here, we demonstrate that c.”
BackgroundMonogenic polyautoimmunity in primary immunodeficiency diseases
Azizi, G., Yazdani, R., Rae, W. M., Abolhassani, H., Rojas, M., Aghamohammadi, A., & Anaya, J. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.05.001 · Cited by 41
Seng, A., Krausz, K. L., Pei, D., Koestler, D. C., Fischer, R. T., Yankee, T. M., & Markiewicz, M. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000965 · Cited by 42
van Herk, E. H., & Velde, A. A. T. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13342 · Cited by 39
Chandrakasan, S., Chandra, S., Saldaña, B. J. D., Torgerson, T. R., & Buchbinder, D. K. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27619 · Cited by 37
Acute and Chronic Inflammation Induces Disease Pathogenesis
Ptaschinski, C., & Lukacs, N. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00002-x · Cited by 47
Towards gene therapy for IPEX syndrome
Borna, Š., Lee, E., Sato, Y., & Bacchetta, R. (2022) · European Journal of Immunology · doi:10.1002/eji.202149210 · Cited by 39
Self-citationType 1 diabetes: A new vision of the disease based on endotypes
Weston, C. S., Boehm, B. O., & Pozzilli, P. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3770 · Cited by 45
Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients
Grant, J., Bourcier, K., Wallace, S., Pan, D., Conway, A. N., Seyfert‐Margolis, V., & Wallace, P. K. (2008) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20446 · Cited by 36
Rapid assessment of in vitro expanded human regulatory T cell function
Ruitenberg, J. J., Boyce, C. S., Hingorani, R., Putnam, A. L., & Ghanekar, S. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.07.001 · Cited by 43
Sui, W., Hou, X., Che, W.-T., Chen, J., Ou, M., Xue, W., & Dai, Y. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.05.014 · Cited by 36
“At the same time, the transcription factor FoxP3 acts as a crucial molecule in Treg cell development and function and is widely used as a nuclear marker for Treg cells [70].”
BackgroundSato, Y., Liu, J., Lee, E., Perriman, R., Roncarolo, M. G., & Bacchetta, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752394 · Cited by 35
Self-citationTissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
Lee, J., Kim, D., & Min, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865593 · Cited by 40
“Unlike the scurfymutation or Foxp3 deletion in mice where Treg cell generation is severely impaired, some IPEX patients still display undisturbed Treg cell generation, suggesting functional defects of Treg cells (17).”
BackgroundWu, K., Bi, Y., Sun, K., Xia, J., Wang, Y., & Wang, C. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02050.x · Cited by 36
Barış, S., Schulze, I., Ozen, A. O., Karakoç-Aydıner, E., Altuncu, E., Karasu, G., Öztürk, M., Lorenz, M. R., Schwarz, K., Vraetz, T., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0059-7 · Cited by 35
“However, the disease severity does not always correlate with the absence of protein expression or with the degree of functional impairment of the suppressive activity [4, 17].”
Kasow, K. A., Morales-Tirado, V. M., Wichlan, D., Shurtleff, S. A., Abraham, A., Persons, D. A., & Riberdy, J. M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.07.005 · Cited by 37
“It was first noted that CD4+CD25− T cells from patients with IPEX exhibit diminished immune function, suggesting a possible role [2].”
BackgroundRamos, T. L., Bolivar-Wagers, S., Jin, S., Thangavelu, G., Simonetta, F., Lin, P., Hirai, T., Saha, A., Koehn, B. H., Su, L., et al. (2022) · Blood · doi:10.1182/blood.2022018440 · Cited by 34
Forkhead box protein 3: Essential immune regulatory role
Tavakoli, N. N., Hambly, B. D., SULLIVAN, D. R., & Bao, S. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.004 · Cited by 34
Vercoulen, Y., Wehrens, E. J., van Teijlingen, N. H., de Jager, W., Beekman, J. M., & Prakken, B. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007183 · Cited by 37
“Thus, the in vivo lack of Treg function could be explained by the decreased production of IL-2 by Teff in these IPEX patients [3,34].”
BackgroundLim, A. Y. F., French, M. A., & Price, P. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a74fad · Cited by 34
Gut redox and microbiome: charting the roadmap to T-cell regulation
Prasad, S., Singh, S., Menge, S., Mohapatra, I., Kim, S., Helland, L. C., Singh, G., & Singh, A. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387903 · Cited by 38
“Interestingly, experimental studies have shown that Foxp3 de fi ciency leads to a lack of CD4 + CD25 hi Tregs, resulting in an inability to control the expansion of effector T-cells (232, 233).”
ResultPrimary Immunodeficiency Masquerading as Allergic Disease
Chan, S. K., & Gelfand, E. W. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.07.008 · Cited by 35
Transcriptional Programs Underlying Cd4 T Cell Differentiation and Functions
Chalmin, F., Humblin, É., Ghiringhelli, F., & Végran, F. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.07.002 · Cited by 35
CD4+CD25+regulatory T cells in systemic sclerosis and other rheumatic diseases
Amelsfort, J. M. R. M.-V., Walter, G. J., & Taams, L. S. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.28 · Cited by 32
Borna, Š., Lee, E., Nideffer, J., Ramachandran, A., Wang, B., Baker, J. B., Mavers, M., Lakshmanan, U., Narula, M., Garrett, A. K.-H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg6822 · Cited by 38
“…that the increase in the frequency of autoreactivity-promoting AA doublets in T eff2 correlated with the frequency of TSDR-demethylated cells in T eff1 , we speculate that the autoreactive T effs expand freely because of the lack of functional T regs in patients with FOXP3 mutations ( 15 ).”
BackgroundSelf-citationZuber, J., Viguier, M. A., Lemaı̂tre, F., Senée, V., Patey, N., Elain, G., Geissmann, F., Fakhouri, F., Ferradini, L., Julier, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.034 · Cited by 31
Zama, D., Cocchi, I., Masetti, R., Specchia, F., Alvisi, P., Gambineri, E., Lima, M., & Pession, A. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-014-0068-4 · Cited by 30
“Recently, evidence that patients with a severe form of IPEX may have circulating FOXP3 T cells, as it is the case of our patient, which suggests that the cellular basis for the disease may be a result of a functional defect of Treg cells [1,26].”
BackgroundZhang, D., Qiu, X., Li, J., Zheng, S., Li, L., & Zhao, H. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0343 · Cited by 32
Loss of 15-lipoxygenase disrupts Treg differentiation altering their pro-resolving functions
Marques, R. M., Gonzalez-Nuñez, M., Walker, M. E., Gómez, E. A., Colas, R. A., Montero‐Melendez, T., Perretti, M., & Dalli, J. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00807-x · Cited by 32
“Of note, deficiencies in Foxp3 cause lymphoproliferation and multiorgan autoimmunity in Scurfy mutant mice and humans with immunodysregulation polyendocrinopathy enteropathy Xlinked [28].”
BackgroundThe Role of Foxp3+ Regulatory T Cells in Kidney Transplantation
Karczewski, M., Karczewski, J., Kostrzewa, A., Wiktorowicz, K., & Głyda, M. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.03.065 · Cited by 30
Regulatory T cells as potential immunotherapy in allergy
Wing, K., & Sakaguchi, S. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000246625.79988.12 · Cited by 30
The immune response to the fVIII gene therapy in preclinical models
Patel, S. R., Lundgren, T. S., Spencer, H. T., & Doering, C. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00494 · Cited by 29
“CD4+ T cells and Tregs induced in the liver were then found to egress to hepatic-draining lymph nodes for further proliferation and differentiation, as indicated by in vivo proliferation of OVA specific CD4+ T cells and expansion of CD4+ CD25+ Foxp3+ Tregs in the draining lymph nodes.”
BackgroundInfluentialPasserini, L., & Bacchetta, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01282 · Cited by 33
Self-citationLong, Y., Li, S., Qin, J., Xie, L., Gan, L., Jie, F., Wu, Y., Li, Y., & Du, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.011 · Cited by 28
Wang, B., Zuo, K., Wu, Y. L., Huang, Q., Qin, W.-S., Zeng, C., Li, L., & Liu, Z.-H. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900111 · Cited by 36
Bergot, A., Chaara, W., Ruggiero, E., Mariotti‐Ferrandiz, E., Dulauroy, S., Schmidt, M., Kalle, C. V., Six, A., & Klatzmann, D. (2015) · European Journal of Immunology · doi:10.1002/eji.201445269 · Cited by 36
“In human and mice [2,3], Treg cells are in fact key players for the control of all immune responses, including responses to self, tumours, microbes and grafts, as well as in inflammation [4–6], and prevent the organism from autoimmune attacks.”
Foxp3 is a key downstream regulator of p53-mediated cellular senescence
Kim, J.-E., Shin, J.-S., Moon, J.-H., Hong, S.-W., Jung, D.-J., Kim, J.-E., Hwang, I.-Y., Shin, Y. J., Gong, E.-Y., Lee, D., et al. (2016) · Oncogene · doi:10.1038/onc.2016.193 · Cited by 32
Severe Gastritis in an Insulin‐dependent Child With an IPEX Syndrome
Scaillon, M., Biervliet, S. V., Bontems, P., Dorchy, H., Hanssens, L. S., Ferster, A., Segers, V., & Cadranel, S. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181a159de · Cited by 27
Pathophysiological lessons from rare associations of immunological disorders
Ronco, P. M., & Dêbiec, H. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-1009-5 · Cited by 27
“IPEX is caused by mutations in the forkhead box protein P3 (FOXP3) gene [30], which induce a dysfunction in CD4+ CD25 T regulatory (T reg) cells and in effector T cells [31].”
BackgroundYang, C., Tian, L., Ling, G. S., Trendell-Smith, N. J., Ma, L., Lo, C., Stott, D. I., Liew, F. Y., & Huang, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838190 · Cited by 32
Searching for the Achilles Heel of FOXP3
Lozano, T., Casares, N., & Lasarte, J. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00294 · Cited by 28
“Mutations in the FKH domain of patients with IPEX have been shown to affect DNA binding (8, 51, 75).”
BackgroundKwon, H., Chen, H., Mathis, D. J., & Benoist, C. O. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718599115 · Cited by 28
Costa‐Carvalho, B. T., de Moraes‐Pinto, M. I., Almeida, L. C., Alves, M. T. D. S., Maia, R. P., de Souza, R. R., Barreto, M., Lourenço, L., Vicente, A. M., Coutinho, A., et al. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02055.x · Cited by 27
McKay, F. C., Swain, L. I., Schibeci, S. D., Rubio, J. P., Kilpatrick, T. J., Heard, R. N., Stewart, G. J., & Booth, D. R. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.02.003 · Cited by 29
Peng, J., Dicker, B. L., Du, W., Tang, F., Nguyen, P., Geiger, T. L., Wong, F. S., & Li, W. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.015 · Cited by 26
Types of Colitis Based on Histology
Sherid, M., & Ehrenpreis, E. D. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.05.004 · Cited by 30
FoxP3 gene promoter polymorphism affects susceptibility to preeclampsia
Norouzian, M., Rahimzadeh, M., Rajaei, M., Arabpour, F., & Naderi, N. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.09.001 · Cited by 25
Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation
Lucarelli, B., Merli, P., Bertaina, V., & Locatelli, F. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1123091 · Cited by 25
Characterization of human invariant natural killer T cells expressing FoxP3
Engelmann, P., Farkas, K., Kis, J. T., Richman, G., Zhang, Z., Liew, C. W., Borowiec, M., Niewczas, M. A., Jalahej, H., & Orban, T. (2011) · International Immunology · doi:10.1093/intimm/dxr040 · Cited by 31
IL-35 improves Treg-mediated immune suppression in atherosclerotic mice
Tao, L., Zhu, J., Chen, Y., Wang, Q., Pan, Y., Yu, Q., Zhou, B., & Zhu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3649 · Cited by 23
“The functions of Treg cells were deficient in patients with immunodysregulation polyendocrinopathy enteropathy X‐linked syndrome and the scrufy (sf) mouse model due to a Foxp3 mutation (7,8), thereby demonstrating the importance of Foxp3 for the functions of Treg cells.”
BackgroundYue, N., Hu, P., Tian, C., Chen, K., Zhao, H., Zhang, Y., Yao, J., Wei, Y., Li, D., & Wang, L. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s492079 · Cited by 30
“148 Furthermore, a lower abundance of Treg cells in the small intestine of CD patients is associated with reduced IL-2 production by ILC3, which is influenced by gut microbes.”
The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics
Mijnheer, G., Prakken, B. J., & van Wijk, F. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835d0ee4 · Cited by 23
Dinwiddie, D. L., Kingsmore, S. F., Caracciolo, S., Rossi, G., Moratto, D., Mazza, C., Sabelli, C., Bacchetta, R., Passerini, L., Magri, C., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.062 · Cited by 21
Self-citationHagiwara, S., Watanabe, T., Kudo, M., Minaga, K., Komeda, Y., Kamata, K., Kimura, M., Hayashi, H., Nakagawa, K., Ueshima, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88824-1 · Cited by 25
Impact of parasitic infection on human gut ecology and immune regulations
Naveed, A., & Abdullah, S. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00091-4 · Cited by 29
“tion in the gastrointestinal tract [84].”
Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease
Hvas, C. L., Kelsen, J., Agnholt, J. S., Dige, A. K., Christensen, L. A., & Dahlerup, J. F. (2010) · Autoimmunity · doi:10.3109/08916930903509064 · Cited by 22
“Studies of IPEX patients indicate that FOXP3 mutations may result in different degrees of qualitative Treg dysfunction and not a complete absence of Tregs, exposing the difficulties in translation of murine FOXP3 studies [32].”
BackgroundPharmacological inhibition of RORC2 enhances human Th17‐Treg stability and function
Boardman, D. A., García, R., Ivison, S. M., Bressler, B. L., Dhar, T. G. M., Zhao, Q., & Levings, M. K. (2020) · European Journal of Immunology · doi:10.1002/eji.201948435 · Cited by 24
Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis
Fukuhara, T., Tomiyama, T., Yasuda, K., Ueda, Y., Ozaki, Y., Son, Y., Nomura, S., Uchida, K., Okazaki, K., & Kinashi, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.043 · Cited by 22
“Those defects likely contribute to autoimmune pathogenesis of Mst1-deficient mice, as previously shown by the association of Treg dysfunction to the induction of multi-organ autoimmune diseases following the disruption of Treg-related genes [30,31,32,33].”
BackgroundRelevance of Commensal Microbiota in the Treatment and Prevention of Inflammatory Bowel Disease
Dasgupta, S., & Kasper, D. L. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318297d884 · Cited by 24
“FOXP3 has been found to be absent or nonfunctional in some patients with severe intestinal inflammation.(18,19) On a more mechanistic level, it has been demonstrated in mice that a defi-”
BackgroundLintas, C., Cappa, M., Comparcola, D., Nobili, V., & Fierabracci, A. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0599-4 · Cited by 22
“The X-linked immune dysregulation, polyendocrinopathy, enteropathy (IPEX), is caused by mutations in the FOX P3 gene [1].”
BackgroundFundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseases
Monteleone, G., Calisi, C., Salvatori, S., & Marafini, I. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1665530 · Cited by 29
Takeyama, H., Mizushima, T., Uemura, M., Haraguchi, N., Nishimura, J., Hata, T., Matsuda, C., Takemasa, I., Ikenaga, M., Murata, K., et al. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4578-y · Cited by 21
Léon, J., Chowdhary, K., Zhang, W., Ramírez, R. N., André‐Schmutz, I., Hur, S., Mathis, D. J., & Benoist, C. O. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113018 · Cited by 23
Bae, K. W., Kim, B. E., Choi, J., Lee, J. H., Park, Y. S., Kim, G.-H., Yoo, H. W., & Seo, J. J. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1588-1 · Cited by 21
“Our patient was diagnosed with T1DM with anti-insulin antibody at 11 months, as a previously described IPEX patient [2].”
BackgroundAPECED: is this a model for failure of T cell and B cell tolerance?
Kluger, N., Ranki, A., & Krohn, K. J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00232 · Cited by 22
Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis
de Sio, F. R. S., Passerini, L., Restelli, S., Valente, M. M., Pramov, A., Maccari, M. E., Sanvito, F., Roncarolo, M. G., Porteus, M. H., & Bacchetta, R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.015 · Cited by 21
Self-citationAn, Y., Xu, F., Wang, M., Zhang, Z. ‐., & Zhao, X. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02574.x · Cited by 21
Ring, S., Thome, M., Pretsch, L., Enk, A., & Mahnke, K. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.06.007 · Cited by 22
Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
Kostoff, R. N. (2014) · Scientometrics · doi:10.1007/s11192-014-1298-3 · Cited by 23
Learning to be tolerant: how T cells keep out of trouble
Holländer, G. A., & Peterson, P. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02093.x · Cited by 25
Passerini, L., de Sio, F. R. S., Porteus, M. H., & Bacchetta, R. (2014) · Current Gene Therapy · doi:10.2174/1566523214666141001123828 · Cited by 21
“While in IPEX patients tTreg cells are present but dysfunctional [16-19], in at least a subset of IPEX-like patients the disease is associated with a reduction in the relative amount of circulating tTreg cells, with consequent imbalance between the regulatory and effector T (Teff) cell compartments [20].”
Self-citationAcosta, M. A. T., Morales‐Nebreda, L., Mambetsariev, N., Helmin, K. A., Liu, Q., Helmin, K. A., Morales‐Nebreda, L., Morales‐Nebreda, L., Cheng, K., Abdala‐Valencia, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci179572 · Cited by 28
The intersection of immune deficiency and autoimmunity
Maggadottir, S. M., & Sullivan, K. E. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000091 · Cited by 20
“suppressive function is variably impaired [7].”
Primary Immunodeficiency Diseases: An Opportunity in Pediatrics for Improving Patient Outcomes
Hernandez-Trujillo, V. P., Scalchunes, C., Hernandez-Trujillo, H. S., Boyle, J. M., Williams, P. V., Boyle, M., & Orange, J. S. (2015) · Clinical Pediatrics · doi:10.1177/0009922815574079 · Cited by 23
The Importance of the Transcription Factor Foxp3 in the Development of Primary Immunodeficiencies
Mertowska, P., Mertowski, S., Podgajna, M., & Grywalska, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040947 · Cited by 21
“Nevertheless, scientists have not shown a clear correlation between genotype and phenotype [181,189,190].”
BackgroundHuman T Regulatory Cells: On the Way to Cognition
Kaczorowski, M., & Jutel, M. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0217-2 · Cited by 22
IPEX as a Consequence of Alternatively Spliced FOXP3
Mailer, R. K. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.594375 · Cited by 25
“, FOXP3-independent type 1 regulatory T cells (71)] and the balance of Treg- and Tcon-cell functions affected by the IPEX mutation (47, 48).”
BackgroundFoxp3 as a marker of tolerance induction versus rejection
Zhang, G. Y., Hu, M., Wang, Y. M., & Alexander, S. I. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32831da83c · Cited by 22
Metadata
- Authors
- Bacchetta, R.
- Affiliations
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Bacchetta, R.
- ORCID
- Bacchetta, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1713-1722
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1472239
- OpenAlex
- W2095671247
- Cited by
- 511
- References
- 55
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 31 · 2016: 21 · 2015: 20 · 2014: 29 · 2013: 33 · 2012: 36
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Università degli Studi di Firenze
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI48779, R01AI048779)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- FOXP3 mutations, IPEX syndrome, regulatory T cells, CD4+CD25high T cells, Treg suppressive function, effector T cells, T cell proliferation inhibition, interleukin-2, interferon-gamma, autoimmunity
- MeSH terms
- Animals, Child, Preschool, Disease Models, Animal, Female, Humans, Infant, Interleukin-2, Leukocytes, Mononuclear, Male, Phenotype, Promoter Regions, Genetic, Protein-Losing Enteropathies, Biomarkers, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Cytokines, Polyendocrinopathies, Autoimmune, Jurkat Cells, Mutation, Missense, Genetic Diseases, X-Linked, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.